Black Rock Inc. Royalty Pharma PLC Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Black Rock Inc. holds 23,017,561 shares of RPRX stock, worth $741 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,017,561
Previous 21,205,841
8.54%
Holding current value
$741 Million
Previous $644 Million
5.75%
% of portfolio
0.01%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding RPRX
# of Institutions
446Shares Held
295MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.27 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.2 Billion0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$546 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$455 Million0.28% of portfolio
-
Viking Global Investors LP12.2MShares$393 Million1.05% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...